Trends in descriptions of palliative care in the cancer clinical practice guidelines before and after enactment of the Cancer Control Act (2007): content analysis.
Cancer clinical practice guideline
Cancer control act [2007]
Content analysis
Palliative care
Qualitative research
Journal
BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685
Informations de publication
Date de publication:
12 Jan 2019
12 Jan 2019
Historique:
received:
13
08
2018
accepted:
07
01
2019
entrez:
15
1
2019
pubmed:
15
1
2019
medline:
18
6
2019
Statut:
epublish
Résumé
Palliative care was a priority issue in the Cancer Control Act enacted in 2007 in Japan, and this has resulted in efforts being made toward educational goals in clinical settings. An investigation of how descriptions of palliative care for the treatment of cancer have changed in clinical practice guidelines (CPGs) could be expected to provide a better understanding of palliative care-related decision-making. This study aimed to identify trends in descriptions of palliative care in cancer CPGs in Japan before and after enactment of the Cancer Control Act. Content analysis was used to count the lines in all relevant CPGs. We then compared the number of lines and the proportion of descriptions mentioning palliative care at two time points: the first survey (selection period: February to June 2007) and the second survey (selection period: February to December 2015). Descriptions from the CPGs were independently selected from the Toho University Medical Media Center and Medical Information Network Distribution Service databases, and subsequently reviewed, by two investigators. Descriptions were analyzed for 10 types of cancer. The proportion of descriptions in the first survey (4.4%; 933/21,344 lines) was similar to that in the second survey (4.5%; 1325/29,269 lines). After the enactment of the Cancer Control Act, an increase was observed in the number, but not in the proportion, of palliative care descriptions in Japanese cancer CPGs. In the future, CPGs can be expected to play a major role in helping cancer patients to incorporate palliative care more smoothly.
Sections du résumé
BACKGROUND
BACKGROUND
Palliative care was a priority issue in the Cancer Control Act enacted in 2007 in Japan, and this has resulted in efforts being made toward educational goals in clinical settings. An investigation of how descriptions of palliative care for the treatment of cancer have changed in clinical practice guidelines (CPGs) could be expected to provide a better understanding of palliative care-related decision-making. This study aimed to identify trends in descriptions of palliative care in cancer CPGs in Japan before and after enactment of the Cancer Control Act.
METHODS
METHODS
Content analysis was used to count the lines in all relevant CPGs. We then compared the number of lines and the proportion of descriptions mentioning palliative care at two time points: the first survey (selection period: February to June 2007) and the second survey (selection period: February to December 2015). Descriptions from the CPGs were independently selected from the Toho University Medical Media Center and Medical Information Network Distribution Service databases, and subsequently reviewed, by two investigators.
RESULTS
RESULTS
Descriptions were analyzed for 10 types of cancer. The proportion of descriptions in the first survey (4.4%; 933/21,344 lines) was similar to that in the second survey (4.5%; 1325/29,269 lines).
CONCLUSIONS
CONCLUSIONS
After the enactment of the Cancer Control Act, an increase was observed in the number, but not in the proportion, of palliative care descriptions in Japanese cancer CPGs. In the future, CPGs can be expected to play a major role in helping cancer patients to incorporate palliative care more smoothly.
Identifiants
pubmed: 30636631
doi: 10.1186/s12904-019-0391-z
pii: 10.1186/s12904-019-0391-z
pmc: PMC6330565
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5Subventions
Organisme : JSPS KAKENHI
ID : 24390128
Références
Palliat Med. 2016 Mar;30(3):270-8
pubmed: 26281854
Lancet Oncol. 2012 Feb;13(2):e58-68
pubmed: 22300860
J Palliat Med. 2004 Dec;7(6):754-73
pubmed: 15684843
Palliat Med. 2004 Jan;18(1):32-8
pubmed: 14982205
Palliat Med. 2006 Dec;20(8):799-804
pubmed: 17148534
Br J Cancer. 2006 Dec 4;95(11):1490-6
pubmed: 17117181
BMJ. 2005 Sep 24;331(7518):648-9
pubmed: 16179678
J Palliat Med. 2015 Jan;18(1):45-9
pubmed: 25495030
JAMA. 1990 Jun 13;263(22):3077, 3081, 3084
pubmed: 2342221
Int J Qual Health Care. 2003 Aug;15(4):359-60
pubmed: 12930051